![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Novartis drug Afinitor® reduces seizures patients with tuberous sclerosis complex
Novartis announced results from a Phase III study showing Afinitor®* (everolimus), when used as an...
The use of Surgical Patch TachoSil (human thrombin/human fibrogen) in Neurological Surgerye is approved...
Takeda Pharmaceutical Company Limited announced that the European Commission has granted an expanded indication for...
Bristol-Myers Squibb’s Opdivo Receives Breakthrough Therapy Designation from US FDA for Previously Treated Recurrent...
Designation based on results of Phase 3 study, CheckMate -141, in which Opdivo met its...
AbbVie, CytomX to co-develop for Probody Drug Conjugates
AbbVie and CytomX Therapeutics, Inc announced that they have entered into a collaboration to...
OFIRMEV (Acetaminophen) Injection Health Economic Data Presented and Specially Recognized at Annual Congress of...
Mallinckrodt plc a leading global specialty biopharmaceutical company announced the results from a retrospective analysis...
Teva announced new data from the Phase III placebo-controlled and randomized First Time Use...
Teva Pharmaceutical Industries Ltd., announced new data from the Phase III placebo-controlled and randomized First...
IMS Health Study: U.S. Drug Spending Growth Reaches 8.5 Percent in 2015
Total spending on medicines in the U.S. reached $310 billion in 2015 on an estimated...
Amgen, UCB Present reports on comparing Romosozumab With Teriparatide
In Phase 3 Open-Label STRUCTURE Study Postmenopausal Women With Osteoporosis Transitioning From Oral Bisphosphonates to...
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer, finds a...
Penn Study Describes the Molecular Cause of Common Cerebrovascular Disease
Cerebral cavernous malformations (CCMs) are clusters of dilated, thin-walled blood vessels in the brain that...